JNP Will Bleed On Failed Trial, CERU Crashes, CYTK Progresses With VITALITY

Juniper Pharmaceuticals Inc.'s (JNP) phase 2b clinical trial of COL-1077, a 10% lidocaine bioadhesive vaginal gel, for the reduction of pain intensity in women undergoing an endometrial biopsy with tenaculum placement, has not achieved the primary and secondary endpoints.

from RTT - Biotech http://ift.tt/2bzhTkQ
via IFTTT